Zevra Therapeutics (ZVRA) EBIT Growth (3y) (2017 - 2026)
Zevra Therapeutics (ZVRA) EBIT Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 82.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.36% |
| Dec 31, 2025 | 44.23% |
| Sep 30, 2025 | 37.95% |
| Jun 30, 2025 | -42.08% |
| Dec 31, 2024 | -75.70% |
| Sep 30, 2024 | -130.77% |
| Jun 30, 2024 | -82.51% |
| Mar 31, 2024 | -70.35% |
| Dec 31, 2023 | -67.70% |
| Sep 30, 2023 | -133.10% |
| Jun 30, 2023 | -64.00% |
| Mar 31, 2023 | -50.35% |
| Dec 31, 2022 | -28.30% |
| Sep 30, 2022 | -59.38% |
| Jun 30, 2022 | -47.03% |
| Dec 31, 2021 | 32.57% |
| Sep 30, 2021 | 50.17% |
| Jun 30, 2021 | 34.25% |
| Mar 31, 2021 | 35.20% |
| Dec 31, 2020 | 26.67% |